ArticleScience China. Life sciences2025
The SWI/SNF complex mediated chromatin remodeling promotes hepatitis B virus cccDNA transcription.
Article in Science China. Life sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- [The E3 ubiquitin ligase KLHL8 degrades HBx protein via the ubiquitin-proteasome pathway and inhibits HBV cccDNA transcription].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026Article
- Review
- SWI/SNF regulated HBV cccDNA transcription as a new target potential to functional cure.Science China. Life sciences · 2026Article
- [Progress in clinical research related to viral hepatitis in 2025].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic hepatitis B is perpetuated by the presence of covalently closed circular DNA (cccDNA) from the hepatitis B virus (HBV) in the liver's hepatocytes. Despite these efforts, the exact mechanisms by which the chromatin structure of cccDNA enables viral persistence remain unclear. This study investigates the vital role of mammalian SWI/SNF chromatin remodeling complexes in regulating the transcriptional activity of cccDNA. Our research, using pharmacological inhibitors and genetic techniques, identifies BRG1 (SMARCA4), the central ATPase of the mSWI/SNF complexes, and BRD9, a non-canonical BAF (ncBAF)-specific subunit, as crucial host factors for HBV replication. The overexpression of SMARCA4 enhances viral propagation, whereas its targeted degradation using PROTAC AU15330 or siRNA significantly reduces cccDNA-driven transcription, viral transcripts, and protein levels. Chromatin accessibility assays demonstrate that the depletion of BRG1 (SMARCA4) compacts the chromatin at critical cccDNA regulatory regions. Mechanistically, the HBV X protein (HBx) interacts with BAF155 and collaborates with transcription factor YY1 to promote the SWI/SNF complex binding to viral chromatin. Interestingly, inhibiting BRD9, an ncBAF-specific acetyl-lysine reader, similarly disrupts cccDNA transcription, indicating a coordinated function of canonical and non-canonical SWI/SNF complexes via acetylation-dependent chromatin remodeling. These insights highlight SWI/SNF complexes as key regulators of viral persistence and suggest targeting these complexes as a potential therapeutic strategy for eradicating cccDNA reservoirs, potentially leading to a functional cure for chronic HBV infection.
Indexed as
Identifiers
41284190What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.